Page 86 - AN-1-2
P. 86

Advanced Neurology                                               NMDA receptors in neuropsychiatric diseases



                https://doi.org/1111/j.1469-7793.1998.013bx.x  332.  Tarabeux J, Kebir O, Gauthier J,  et al., 2011, Rare
                                                                   mutations in N-methyl-D-aspartate glutamate receptors
            323.  Mayer ML, 2006, Glutamate receptors at atomic resolution.
                Nature, 440: 456–462.                              in autism spectrum disorders and schizophrenia.  Transl
                                                                   Psychiatry, 1: e55.
                https://doi.org/1038/nature04709
                                                                   https://doi.org/1038/tp.2011.52
            324.  Gao K, Tankovic A, Zhang Y, et al., 2017, A de novo loss-  333.  Retterer K,  Juusola J,  Cho  MT,  et al.,  2016,  Clinical
                of-function GRIN2A mutation associated with childhood   application of whole-exome sequencing across clinical
                focal epilepsy and acquired epileptic aphasia. PLoS One, 12:   indications. Genet Med, 18: 696–704.
                e0170818.
                                                                   https://doi.org/1038/gim.2015.148
                https://doi.org/1371/journal.pone.0170818
                                                               334.  Wells G, Yuan H, McDaniel MJ, et al., 2018, The GluN2B-
            325.  Swanger SA, Chen W, Wells  G,  et al., 2016, Mechanistic   Glu413Gly NMDA receptor variant arising from a de novo
                insight into nmda receptor dysregulation by rare variants in   GRIN2B mutation promotes ligand-unbinding and domain
                the GluN2A and GluN2B agonist binding domains. Am J   opening. Proteins, 86: 1265–1276.
                Hum Genet, 99: 1261–1280.
                                                                   https://doi.org/1002/prot.25595
                https://doi.org/1016/j.ajhg.2016.10.002
                                                               335.  Shin W, Kim K, Serraz B, et al., 2020, Early correction of
            326.  Vieira MM, Nguyen TA, Wu K, et al., 2020, An epilepsy-  synaptic long-term depression improves abnormal anxiety-
                associated GRIN2A rare variant disrupts CaMKIIalpha   like behavior in adult GluN2B-C456Y-mutant mice. PLoS
                phosphorylation of GluN2A and NMDA receptor        Biol, 18: e3000717.
                trafficking. Cell Rep, 32: 108104.
                                                                   https://doi.org/1371/journal.pbio.3000717
                https://doi.org/1016/j.celrep.2020.108104
                                                               336.  Soto D, Olivella M, Grau C, et al., 2019, L-Serine dietary
            327.  Fedele L, Newcombe J, Topf M,  et al., 2018, Disease-  supplementation is associated with clinical improvement of
                associated missense mutations in GluN2B subunit alter   loss-of-function GRIN2B-related pediatric encephalopathy.
                NMDA receptor ligand binding and ion channel properties.   Sci Signal, 12: eaaw0936.
                Nat Commun, 9: 957.
                                                                   https://doi.org/1126/scisignal.aaw0936
                https://doi.org/1038/s41467-018-02927-4
                                                               337.  Lemke JR, Hendrickx R, Geider K,  et al., 2014, GRIN2B
            328.  Glasgow NG, Retchless BS, Johnson JW, 2015, Molecular   mutations in West syndrome and intellectual disability with
                bases of NMDA receptor subtype-dependent properties.   focal epilepsy. Ann Neurol, 75: 147–154.
                J Physiol, 593: 83–95.
                                                                   https://doi.org/1002/ana.24073
                https://doi.org/1113/jphysiol.2014.273763
                                                               338.  Mullier B, Wolff C, Sands ZA, et al., 2017, GRIN2B gain of
            329.  Andreoli V, De Marco EV, Trecroci F, et al., 2014, Potential   function mutations are sensitive to radiprodil, a negative
                involvement of GRIN2B encoding the NMDA receptor   allosteric modulator of GluN2B-containing NMDA
                subunit  NR2B in the spectrum of Alzheimer’s disease.   receptors. Neuropharmacology, 123: 322–331.
                J Neural Transm, 121: 533–542.
                                                                   https://doi.org/1016/j.neuropharm.2017.05.017
                https://doi.org/1007/s00702-013-1125-7
                                                               339.  Li D, Yuan H, Ortiz-Gonzalez XR,  et al., 2016, GRIN2D
            330.  Myers RA, Casals F, Gauthier J, et al., 2011, A population   recurrent  de novo dominant  mutation causes a severe
                genetic approach to mapping neurological disorder genes   epileptic  encephalopathy  treatable  with  NMDA  receptor
                using deep resequencing. PLoS Genet, 7: e1001318.   channel blockers. Am J Human Genet, 99: 802–816.
                https://doi.org/1371/journal.pgen.1001318          https://doi.org/1016/j.ajhg.2016.07.013
            331.  Hu C, Chen W, Myers SJ,  et al., 2016, Human GRIN2B   340.  Chen HS, Lipton SA, 2006, The chemical biology of clinically
                variants in neurodevelopmental disorders. J Pharmacol Sci,   tolerated NMDA receptor antagonists.  J  Neurochem,
                132: 115–121.                                      97: 1611–1626.
                https://doi.org/1016/j.jphs.2016.10.002            https://doi.org/1111/j.1471-4159.2006.03991.x













            Volume 1 Issue 2 (2022)                         30                      https://doi.org/10.36922/an.v1i2.148
   81   82   83   84   85   86   87   88   89   90   91